メタ情報
| meta description平均長 | 23 |
|---|
| OGPありページ数 | 13 |
|---|
| Twitterカードありページ数 | 13 |
|---|
内部リンク分析(Internal)
| ユニーク内部リンク数 | 22 |
|---|
| ページあたり内部リンク平均 | 36.62 |
|---|
連絡先候補(Contacts)
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|
| your | 1 |
| personal | 0.864865 |
| you | 0.837838 |
| data | 0.726191 |
| information | 0.594595 |
| website | 0.351351 |
| any | 0.351351 |
| will | 0.339919 |
| have | 0.324324 |
| toxin | 0.302048 |
| processing | 0.297297 |
| web | 0.297297 |
| Pipeline | 0.278116 |
| our | 0.278116 |
| Member | 0.276126 |
| browser | 0.27027 |
| OBI | 0.267357 |
| botulinum | 0.261775 |
| not | 0.256403 |
| Ltd | 0.243243 |
| visit | 0.243243 |
| Data | 0.23668 |
| Phase | 0.22812 |
| University | 0.216956 |
| please | 0.216216 |
| unit | 0.189189 |
| privacy | 0.189189 |
| Notice | 0.189189 |
| may | 0.189189 |
| consent | 0.189189 |
| third | 0.189189 |
| cookies | 0.189189 |
| safety | 0.186293 |
| company | 0.185411 |
| its | 0.185411 |
| trial | 0.181229 |
| efficacy | 0.17751 |
| startup | 0.162162 |
| engages | 0.162162 |
| protect | 0.162162 |
| GDPR | 0.162162 |
| Privacy | 0.161454 |
| manufacturing | 0.157786 |
| first | 0.154509 |
| research | 0.154509 |
| Announcements | 0.154509 |
| News | 0.154509 |
| Events | 0.154509 |
| market | 0.149035 |
| Investors | 0.139058 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| botulinum | toxin | 3.857475 | 104 |
| browser | web | 3.409358 | 42 |
| Company | Overview | 3.406083 | 48 |
| Events | News | 3.396466 | 39 |
| Management | Team | 3.32664 | 43 |
| Calendar | Event | 3.253182 | 36 |
| Careers | Events | 3.229964 | 34 |
| Organization | Structure | 3.214145 | 39 |
| Organization | Team | 3.208086 | 40 |
| Directors | Management | 3.204136 | 42 |
| Calendar | News | 3.201449 | 36 |
| Announcements | Investors | 3.168727 | 36 |
| Announcements | Event | 3.168727 | 36 |
| Pipeline | Structure | 3.055303 | 36 |
| Board | Directors | 2.868029 | 46 |
| Careers | News | 2.824717 | 29 |
| identifiable | personally | 2.777713 | 20 |
| Notice | Privacy | 2.71856 | 28 |
| clinical | trial | 2.71533 | 47 |
| Board | Overview | 2.706016 | 44 |
| development | research | 2.683448 | 32 |
| data | personal | 2.682108 | 91 |
| 10U | 20U | 2.668714 | 20 |
| Directors | Overview | 2.661094 | 33 |
| Phase | clinical | 2.653867 | 55 |
| Directors | Team | 2.640217 | 31 |
| Board | Member | 2.631044 | 45 |
| Event | Investors | 2.621843 | 27 |
| Calendar | Events | 2.621843 | 27 |
| Announcements | Calendar | 2.620865 | 28 |
| Structure | Team | 2.617458 | 29 |
| company | startup | 2.613042 | 28 |
| moderate | severe | 2.595345 | 16 |
| engages | research | 2.591442 | 24 |
| Event | News | 2.576969 | 27 |
| Management | Organization | 2.533659 | 31 |
| Investors | Pipeline | 2.495073 | 27 |
| biotechnology | startup | 2.467557 | 20 |
| glabellar | lines | 2.467557 | 20 |
| Ltd | Member | 2.460167 | 29 |
| Chou | Patricia | 2.419739 | 17 |
| tolerated | well | 2.379235 | 16 |
| analysis | interim | 2.379235 | 16 |
| Biofund | Diamond | 2.36066 | 12 |
| CPA | qualifications | 2.36066 | 12 |
| people | pursue | 2.36066 | 12 |
| significance | statistical | 2.36066 | 12 |
| Nan | Shan | 2.36066 | 12 |
| Organization | Pipeline | 2.343017 | 27 |
| Assurance | Quality | 2.339006 | 11 |